FRAMINGHAM, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that Terrence W. Norchi, MD, Chief Executive Officer, will present at the H.C. Wainwright 22nd Annual Global Investment Conference… Read More..

ANN ARBOR, Mich., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for companion animals, announced today that Robert Cohen, Interim Chief Executive Officer, and Stephanie Morley, President and Chief Medical Officer, will present at the upcoming H.C. Wainwright… Read More..

Preclinical data supports potential for: - Broadly applicable vaccine (young, elderly, immunocompromised) - Rapid onset of immunogenicity within 7 days of the first dose - Thermostabilized vaccine (ambient storage/shipping with no need for cold chain) - Multivalent vaccine formulation, if needed - Readily adaptable vaccine for seasonal vaccination use, if… Read More..